Lovastatin blocks basic fibroblast growth factor-induced mitogen-activated protein kinase signaling in coronary smooth muscle cells via phosphatase inhibition

This publication has 28 references indexed in Scilit:

• Effect of inhibition of cholesterol synthetic pathway on the activation of Ras and MAP kinase in mesangial cells
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1999
• Regulation of Syndecan-4 Phosphorylation in Vivo
  Published by Elsevier ,1998
• Phosphorylation of threonine 638 critically controls the dephosphorylation and inactivation of protein kinase Cα
  Current Biology, 1996
• Multiple intracellular MAP kinase signaling cascades
  Kidney International, 1996
• Translational Control of p27 ^Kip1 Accumulation During the Cell Cycle
  Science, 1996
• Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction
  The FASEB Journal, 1995
• Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase, but not CL100, in various cell lines
  Current Biology, 1995
• Mitogen-activated Protein (MAP) Kinase Is Regulated by the MAP Kinase Phosphatase (MKP-1) in Vascular Smooth Muscle Cells
  Published by Elsevier ,1995
• Simvastatin inhibits PDGF-induced DNA synthesis in human glomerular mesangial cells
  Kidney International, 1993
• Regulation of the mevalonate pathway
  Nature, 1990